Fibroblast-derived EGF ligand neuregulin 1 induces fetal-like reprogramming of the intestinal epithelium without supporting tumorigenic growth

dc.contributor.authorLemmetyinen Toni T.
dc.contributor.authorViitala Emma W.
dc.contributor.authorWartiovaara Linnea
dc.contributor.authorKaprio Tuomas
dc.contributor.authorHagström Jaana
dc.contributor.authorHaglund Caj
dc.contributor.authorKatajisto Pekka
dc.contributor.authorWang Timothy C.
dc.contributor.authorDomeǹech-Moreno Eva
dc.contributor.authorOllila Saara
dc.contributor.organizationfi=hammaslääketieteen laitos|en=Institute of Dentistry|
dc.contributor.organization-code1.2.246.10.2458963.20.64787032594
dc.converis.publication-id179606430
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/179606430
dc.date.accessioned2025-08-28T00:34:27Z
dc.date.available2025-08-28T00:34:27Z
dc.description.abstract<p>Growth factors secreted by stromal fibroblasts regulate the intestinal epithelium. Stroma-derived epidermal growth factor (EGF) family ligands are implicated in epithelial regeneration and tumorigenesis, but their specific contributions and associated mechanisms remain unclear. Here, we use primary intestinal organoids modeling homeostatic, injured and tumorigenic epithelia to assess how the fibroblast-derived EGF family ligands neuregulin 1 (NRG1) and epiregulin (EREG) regulate the intestinal epithelium. NRG1 was expressed exclusively in the stroma, robustly increased crypt budding and protected intestinal epithelial organoids from radiation-induced damage. NRG1 also induced regenerative features in the epithelium, including a fetal-like transcriptome, suppression of the Lgr5<sup>+</sup> stem cell pool and remodeling of the epithelial actin cytoskeleton. Intriguingly, unlike EGF and EREG, NRG1 failed to support the growth of pre-tumorigenic intestinal organoids lacking the tumor suppressor Apc, commonly mutated in human colorectal cancer (CRC). Interestingly, high expression of stromal NRG1 was associated with improved survival in CRC cohorts, suggesting a tumor-suppressive function. Our results highlight the power of stromal NRG1 in transcriptional reprogramming and protection of the intestinal epithelium from radiation injury without promoting tumorigenesis. © 2023. Published by The Company of Biologists Ltd.</p><h3>Author keywords</h3><p>Colorectal cancer; EGF; EREG; Intestinal regeneration; NRG1</p>
dc.identifier.jour-issn1754-8403
dc.identifier.olddbid205967
dc.identifier.oldhandle10024/188994
dc.identifier.urihttps://www.utupub.fi/handle/11111/38579
dc.identifier.urlhttps://doi.org/10.1242/dmm.049692
dc.identifier.urnURN:NBN:fi-fe2023052748860
dc.language.isoen
dc.okm.affiliatedauthorHagström, Jaana
dc.okm.discipline3122 Cancersen_GB
dc.okm.discipline3122 Syöpätauditfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherCompany of Biologists Ltd
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.doi10.1242/dmm.049692
dc.relation.ispartofjournalDisease Models and Mechanisms
dc.relation.issue4
dc.relation.volume16
dc.source.identifierhttps://www.utupub.fi/handle/10024/188994
dc.titleFibroblast-derived EGF ligand neuregulin 1 induces fetal-like reprogramming of the intestinal epithelium without supporting tumorigenic growth
dc.year.issued2023

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
dmm049692.pdf
Size:
10.38 MB
Format:
Adobe Portable Document Format